ANGIODYNAMICS INC — Director's Dealing 2015

Jul 24, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2015-07-22

Reporting Person: Greiner Charles R (VP - Global Franchise)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-07-22	Common Stock	A	4126	—	Acquired	26181	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-22	Non-Qualified Stock Option (right to buy)	$15.95	A	14153	Acquired	2022-07-22	Common Stock (14153)	Direct
2015-07-22	Performance Right	$	A	5501	Acquired		Common Stock (5501)	Direct

Footnotes

F1: This acquisition of 4,126 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 4,126 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 22, 2016, such that 25% of the restricted stock units will vest on each of July 22, 2016, 2017, 2018 and 2019.

F2: These stock options vest in four equal annual installments beginning on July 22, 2016, such that 25% of the options will vest on each of July 22, 2016, 2017, 2018 and 2019.

F3: Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2016, 2017 and 2018. Any shares that do not vest at the end of the performance period will be forfeited.